Vestcor Inc’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$562K Hold
15,438
– – 0.01% 736
2026
Q1
$432K Hold
15,438
– – 0.01% 784
2025
Q4
$578K Hold
15,438
– – 0.02% 662
2025
Q3
$425K Buy
15,438
+10,967
+245% +$378K 0.01% 767
2025
Q2
$141K Hold
4,471
– – ﹤0.01% 1025
2025
Q1
$148K Hold
4,471
– – 0.01% 1019
2024
Q4
$154K Hold
4,471
– – 0.01% 1034
2024
Q3
$179K Hold
4,471
– – 0.01% 980
2024
Q2
$135K Hold
4,471
– – ﹤0.01% 1021
2024
Q1
$150K Hold
4,471
– – 0.01% 1034
2023
Q4
$144K Hold
4,471
– – ﹤0.01% 1045
2023
Q3
$147K Buy
+4,471
New +$155K 0.01% 1066

Other funds holding HRMY

Vestcor Inc's HRMY Position: Q2 2026 in Review

Vestcor Inc held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 15,438 shares worth $562K. The position accounts for 0.01% of the portfolio, ranked #736.

Vestcor Inc first reported a position in HRMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $578K in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Vestcor Inc held 15,438 shares of Harmony Biosciences worth $562K as of Q2 2026.
  • Vestcor Inc left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up 0.01% of Vestcor Inc's portfolio in Q2 2026, its #736 holding.
  • Vestcor Inc first reported a position in Harmony Biosciences in Q3 2023 and has held it in 12 quarters since.
  • Vestcor Inc's Harmony Biosciences position peaked at $578K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.